<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Thanks to investigations that have revealed the favorable impact of ketone bodies on cellular metabolism in many tissues, KD has also been evaluated for numerous other neurological and neuromuscular disorders [
 <xref rid="B26-nutrients-11-01104" ref-type="bibr" class="xref">26</xref>,
 <xref rid="B27-nutrients-11-01104" ref-type="bibr" class="xref">27</xref>], like mitochondrial, Parkinson’s, and Alzheimer’s disease, migraine/headache, depression, glycogenosis, high grade glioblastoma [
 <xref rid="B28-nutrients-11-01104" ref-type="bibr" class="xref">28</xref>], and amyotrophic lateral sclerosis, as well as for metabolic and endocrine disorders like diabetes, obesity, metabolic syndrome, poly-cystic ovary syndrome, and congenital hyperinsulinism [
 <xref rid="B29-nutrients-11-01104" ref-type="bibr" class="xref">29</xref>,
 <xref rid="B30-nutrients-11-01104" ref-type="bibr" class="xref">30</xref>,
 <xref rid="B31-nutrients-11-01104" ref-type="bibr" class="xref">31</xref>]. Recent reviews have summarized the studies exploring the effects of KDs in the treatment of specific neurological disorders, and the clinical studies investigating the efficacy of KDs in the management of different neurological disorders in adults [
 <xref rid="B22-nutrients-11-01104" ref-type="bibr" class="xref">22</xref>,
 <xref rid="B27-nutrients-11-01104" ref-type="bibr" class="xref">27</xref>].
</p>
